These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
    Author: Sterkers G, Henin Y, Kalil J, Bagot M, Levy JP.
    Journal: J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663.
    Abstract:
    L1-16, a DR-specific, nonpolymorphic monoclonal antibody (MoAb) recognizing the beta-chain of the molecule, blocked virus-specific as well as allogeneic-proliferative T cell responses, whereas another nonpolymorphic anti-DR MoAb blocked proliferative responses to allogeneic cells only. IL 2-supernatants reversed the blocking induced by L1-16. On the other hand class I-specific MoAb B1-23-2 (HLA-A-B-C-specific) and M 18 (beta 2 microglobulin-specific) and their F(ab')2 fragments blocked equally virus-specific or allogeneic proliferative responses. IL 2-containing supernatants did not reverse this phenomenon. Neither anti-class I nor anti-class II MoAb inhibited the IL 2-induced proliferation of IL 2-dependent established T cell lines. MoAb acted neither at the antigen-presenting cell level nor by a toxic effect nor by inducing suppressor cells. These results suggest that a) different epitopes of the DR molecule can be involved during responses to influenza viruses and allogeneic antigens; b) the epitope recognized by L1-16 on the beta-chain of the DR molecule seem necessary for IL 2 production by lymphocytes after activation with influenza antigens; and c) class I-specific MoAb block DR-restricted proliferative responses of lymphocytes by an as yet unknown mechanism.
    [Abstract] [Full Text] [Related] [New Search]